Baird Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $369M | Sell |
|
|||||
|
2025
Q1 | $424M | Sell |
|
|||||
|
2024
Q4 | $370M | Sell |
|
|||||
|
2024
Q3 | $417M | Sell |
|
|||||
|
2024
Q2 | $365M | Sell |
|
|||||
|
2024
Q1 | $393M | Buy |
|
|||||
|
2023
Q4 | $325M | Buy |
|
|||||
|
2023
Q3 | $311M | Sell |
|
|||||
|
2023
Q2 | $286M | Sell |
|
|||||
|
2023
Q1 | $380M | Buy |
|
|||||
|
2022
Q4 | $382M | Sell |
|
|||||
|
2022
Q3 | $376M | Sell |
|
|||||
|
2022
Q2 | $482M | Sell |
|
|||||
|
2022
Q1 | $526M | Buy |
|
|||||
|
2021
Q4 | $435M | Buy |
|
|||||
|
2021
Q3 | $344M | Buy |
|
|||||
|
2021
Q2 | $357M | Buy |
|
|||||
|
2021
Q1 | $342M | Buy |
|
|||||
|
2020
Q4 | $335M | Buy |
|
|||||
|
2020
Q3 | $266M | Sell |
|
|||||
|
2020
Q2 | $303M | Buy |
|
|||||
|
2020
Q1 | $221M | Sell |
|
|||||
|
2019
Q4 | $258M | Buy |
|
|||||
|
2019
Q3 | $211M | Buy |
|
|||||
|
2019
Q2 | $194M | Buy |
|
|||||
|
2019
Q1 | $148M | Buy |
|
|||||
|
2018
Q4 | $167M | Buy |
|
|||||
|
2018
Q3 | $134M | Sell |
|
|||||
|
2018
Q2 | $156M | Buy |
|
|||||
|
2018
Q1 | $148M | Sell |
|
|||||
|
2017
Q4 | $164M | Sell |
|
|||||
|
2017
Q3 | $155M | Sell |
|
|||||
|
2017
Q2 | $140M | Sell |
|
|||||
|
2017
Q1 | $153M | Buy |
|
|||||
|
2016
Q4 | $143M | Buy |
|
|||||
|
2016
Q3 | $127M | Sell |
|
|||||
|
2016
Q2 | $137M | Sell |
|
|||||
|
2016
Q1 | $128M | Buy |
|
|||||
|
2015
Q4 | $129M | Buy |
|
|||||
|
2015
Q3 | $115M | Buy |
|
|||||
|
2015
Q2 | $140M | Buy |
|